mCRC Patients In Practice
This module is designed to educate healthcare professionals on how to individualise treatment for a range of metastatic colorectal cancer (mCRC) patients whilst considering different prognostic and predictive biomarkers, and other clinical factors.
Through a series of interactive case studies, learn how to treat different cases of mCRC with expert commentary from leading Australian oncologists Prof. Stephen Clarke, Prof. Desmond Yip and Dr Mark Wong, and review key data from Avastin (bevacizumab) clinical trials treating a broad range of mCRC patient types.
This module will take about one hour to complete.
- Presenter(s):Prof Desmond Yip
Prof Stephen Clarke
- Host:Roche Oncology
- QI&CPD Points:Self Reported